-
Sanofi-Aventis Sending “Dear Doctor” Letter About Ketek Label Changes
Bolded Warning, But Not "Black Box", For Liver Problems And Reports Of Deaths In late June 2006 Sanofi-Aventis SA announced that it had added a new bolded warning about the risks of liver failure…
-
Did Merck Design Its Studies To Avoid Exposing The Risks Of Vioxx?
March 2005 Vioxx Article Says "Yes", Meaning That Only Merck Could Make An "Informed Decision" About The Risks For Heart Attacks And Strokes Hats off to "Insider" over at the PharmaGossip blog for resurrecting…
-
First California Vioxx Trial Started On June 21: Grossberg v. Merck
Trial Consists Of Only Single Case, Not The Four-Case Group Judge Chaney Had Scheduled A June 21, 2006 article in the San Jose Mercury News reported that the first Vioxx trial in California started…
-
Cox-2 Drugs Increase Risk Of Second Heart Attack Or Death When Used After First Heart Attack
Will June 2006 Circulation Article Affect Lawsuits Involving Bextra, Celebrex, And Vioxx? In mid-June 2006 the medical journal Circulation published online an early-release version of a study which reveals that Bextra, Celebrex, and Vioxx…
-
Beware Of Deception By Drug Companies: Former NEJM Editor In Chief
Prescription Drug Companies Have Used Deceptive Practices: NJ Public Interest Research Group Going back in time a bit, the March 1, 2005 edition of Bottom Line/Health featured an excellent article for patients and doctors,…
